RANDOMIZED TRIAL OF LOW VS HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN THE TREATMENT OF POST-MENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

被引：0
|
作者：
CAVALLI, F [1 ]
GOLDHIRSCH, A [1 ]
JUNGI, G [1 ]
MARTZ, G [1 ]
MERMILLOD, B [1 ]
SCHAFER, P [1 ]
ALBERTO, P [1 ]
机构：
[1] SWISS GRP CLIN CANC RES,GENEVA,SWITZERLAND
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1983年 / 19卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：R11 / R11
页数：1
相关论文
共 50 条
  • [31] A RANDOMIZED COMPARISON OF MEGESTROL-ACETATE (MA) AND MEDROXYPROGESTERONE ACETATE (MPA) IN PATIENTS WITH ADVANCED BREAST-CANCER
    WILLEMSE, PHB
    VANDERPLOEG, E
    SLEIJFER, DT
    TJABBES, T
    VANVEELEN, H
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (03) : 337 - 343
  • [32] AMINOGLUTETHIMIDE IN THE TREATMENT OF ADVANCED POST-MENOPAUSAL BREAST-CANCER
    HARRIS, AL
    POWLES, TJ
    SMITH, IE
    CANCER RESEARCH, 1982, 42 (08) : 3405 - 3408
  • [33] PHARMACOKINETICS AND METABOLISM OF MEDROXYPROGESTERONE ACETATE (MPA) IN PATIENTS WITH ADVANCED BREAST-CANCER
    UTAAKER, E
    LUNDGREN, S
    KVINNSLAND, S
    ASKVAAG, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (06): : 739 - 739
  • [34] RANDOMIZED STUDY COMPARING TAMOXIFEN (TMX)-MEDROXYPROGESTERONE ACETATE (MPA) ALTERNATED VS MPA ALONE IN ADVANCED BREAST-CANCER
    SANCHIZ, F
    BELON, J
    CRUZHERNANDEZ, JJ
    NAVARRETE, A
    ALONSO, J
    DIAZFAES, JG
    LIZON, J
    BARON, MG
    ARANDA, E
    JIMENO, J
    MILLA, A
    ANTICANCER RESEARCH, 1986, 6 (03) : 372 - 372
  • [35] THERAPEUTIC EFFECT OF TAMOXIFEN VERSUS TAMOXIFEN COMBINED WITH MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER IN POST-MENOPAUSAL WOMEN
    MOURIDSEN, HT
    ELLEMANN, K
    MATTSSON, W
    PALSHOF, T
    DAEHNFELDT, JL
    ROSE, C
    CANCER TREATMENT REPORTS, 1979, 63 (02): : 171 - 175
  • [36] ADRENAL SUPPRESSION BY ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER PATIENTS
    VANVEELEN, H
    WILLEMSE, PHB
    SLEIJFER, DT
    PRATT, JJ
    SLUITER, WJ
    DOORENBOS, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 12 (02) : 83 - 86
  • [37] HIGH-DOSE MEDROXYPROGESTERONE ACETATE PLUS MITOMYCIN-C OR VINDESINE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, HC
    FALKSON, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 431 - 434
  • [38] MECHANISM OF ADRENAL SUPPRESSION BY HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN BREAST-CANCER PATIENTS
    VANVEELEN, H
    WILLEMSE, PHB
    SLEIJFER, DT
    VANDERPLOEG, E
    SLUITER, WJ
    DOORENBOS, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (02) : 167 - 170
  • [39] A PHASE-II STUDY OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    FALKSON, G
    FALKSON, HC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1983, 11 (01) : 16 - 18
  • [40] ORAL VERSUS IM ADMINISTRATION OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER
    BEEX, L
    BURGHOUTS, J
    VANTURNHOUT, J
    BREED, W
    HILLEN, H
    HOLDRINET, A
    BOETIUS, G
    HOOGENDOORN, G
    DOESBURG, W
    VERHULST, M
    MEULENBERG, P
    CANCER TREATMENT REPORTS, 1987, 71 (12): : 1151 - 1156
12345